MedTrace Logo

Cologne Placenta Cohort (CPC)

NCT05424965 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 247

Last updated 2022-06-21

No results posted yet for this study

Summary

Aim of the study was to determine if signaling pathways in placentas of mothers affected by overweight/obesity or by gestational diabetes are altered compared to placentas of a control group (normal weight, no gestational diabetes). Moreover, maternal blood and umbilical cord blood were analysed.

Conditions

  • Obesity, Maternal
  • Gestational Diabetes Mellitus in Pregnancy

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • Sarah Appel

    lead OTHER

Principal Investigators

  • Sarah Appel, Dr. · Universitätsklinikum Köln

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-23
Primary Completion
2020-11-06
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05424965 on ClinicalTrials.gov